Synergistic Combination of an Intelligent Nanozyme and Radiotherapy for Treating Renal Cancer

References

• Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi:10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Dinges SS, Hohm A, Vandergrift LA, et al. Cancer metabolomic markers in urine: evidence, techniques and recommendations. Nat Rev Urol. 2019;16(6):339–362. doi:10.1038/s41585-019-0185-3
   PubMed Web of Science ®Google Scholar
• Andrews JR, Atwell T, Schmit G, et al. Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2019;76(2):244–251. doi:10.1016/j.eururo.2019.04.026
   PubMed Web of Science ®Google Scholar
• Bravi CA, Larcher A, Capitanio U, et al. Perioperative outcomes of open, laparoscopic, and robotic partial nephrectomy: a prospective multicenter observational study (The RECORd 2 Project). Eur Urol Focus. 2021;7(2):390–396. doi:10.1016/j.euf.2019.10.013
   PubMedGoogle Scholar
• Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–1904. doi:10.1007/s00345-019-02984-4
   PubMed Web of Science ®Google Scholar
• Obradovic A, Chowdhury N, Haake SM, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184(11):2988–3005.e16. doi:10.1016/j.cell.2021.04.038
   PubMed Web of Science ®Google Scholar
• Campbell Steven C, Uzzo Robert G, Karam Jose A, Chang Sam S, Clark Peter E, Souter L. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II. J Urol. 2021;206(2):209–218. doi:10.1097/JU.0000000000001912
   PubMedGoogle Scholar
• Pan W-L, Tan Y, Meng W, et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022;283:121449. doi:10.1016/j.biomaterials.2022.121449
   PubMed Web of Science ®Google Scholar
• Wang M, Chang M, Li C, et al. Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic cascade cancer starvation/chemodynamic /immunotherapy. Adv Mater. 2022;34(4):2106010. doi:10.1002/adma.202106010
   Web of Science ®Google Scholar
• Zhu Y, Wang W, Cheng J, et al. Stimuli-responsive manganese single-atom nanozyme for tumor therapy via integrated cascade reactions. Angew Chem Int Ed Engl. 2021;60(17):9480–9488. doi:10.1002/anie.202017152
   PubMed Web of Science ®Google Scholar
• Jiang C, He T, Tang Q, et al. Nanozyme catalyzed cascade reaction for enhanced chemodynamic therapy of low-H2O2 tumor. Appl Mater Today. 2022;26:101357. doi:10.1016/j.apmt.2021.101357
   Web of Science ®Google Scholar
• Zhen W, Liu Y, Wang W, et al. Specific “unlocking” of a nanozyme-based butterfly effect to break the evolutionary fitness of chaotic tumors. Angew Chem Int Ed Engl. 2020;59(24):9491–9497. doi:10.1002/anie.201916142
   PubMed Web of Science ®Google Scholar
• Wang M, Wang D, Chen Q, Li C, Li Z, Lin J. Recent advances in glucose-oxidase-based nanocomposites for tumor therapy. Small. 2019;15(51):1903895. doi:10.1002/smll.201903895
   PubMed Web of Science ®Google Scholar
• Fang C, Deng Z, Cao G, et al. Co–ferrocene MOF/glucose oxidase as cascade nanozyme for effective tumor therapy. Adv Funct Mater. 2020;30(16):1910085. doi:10.1002/adfm.201910085
   Web of Science ®Google Scholar
• Wang M, Chang M, Zheng P, et al. A noble AuPtAg-GOx nanozyme for synergistic tumor immunotherapy induced by starvation therapy-augmented mild photothermal therapy. Adv Sci. 2022;9(31):2202332. doi:10.1002/advs.202202332
   Web of Science ®Google Scholar
• Zhang J, Liang C, Wei Z, et al. TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy. Biomaterials. 2022;287:121682. doi:10.1016/j.biomaterials.2022.121682
   PubMedGoogle Scholar
• Li C, Wan Y, Zhang Y, et al. In situ sprayed starvation/chemodynamic therapeutic gel for post-surgical treatment of IDH1 (R132H) glioma. Adv Mater. 2022;34(5):2103980. doi:10.1002/adma.202103980
   Web of Science ®Google Scholar
• Xu B, Cui Y, Wang W, et al. Immunomodulation-enhanced nanozyme-based tumor catalytic therapy. Adv Mater. 2020;32(33):2003563. doi:10.1002/adma.202003563
   Web of Science ®Google Scholar
• Cong C, He Y, Zhao S, et al. Diagnostic and therapeutic nanoenzymes for enhanced chemotherapy and photodynamic therapy. J Mater Chem B. 2021;9(18):3925–3934. doi:10.1039/D0TB02791J
   PubMed Web of Science ®Google Scholar
• Hua Y, Huang J-H, Shao Z-H, et al. Composition-dependent enzyme mimicking activity and radiosensitizing effect of bimetallic clusters to modulate tumor hypoxia for enhanced cancer therapy. Adv Mater. 2022;n/a(n/a):2203734. doi:10.1002/adma.202203734
   Google Scholar
• Yu Z, Lou R, Pan W, Li N, Tang B. Nanoenzymes in disease diagnosis and therapy. Chem Comm. 2020;56(99):15513–15524. doi:10.1039/D0CC05427E
   PubMed Web of Science ®Google Scholar
• Li Z-L, Wu H, Zhu J-Q, et al. Novel strategy for optimized nanocatalytic tumor therapy: from an updated view. Small Sci. 2022;2(7):2200024. doi:10.1002/smsc.202200024
   Google Scholar
• Zhu D, Ling R, Chen H, et al. Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy. Nano Res. 2022;15(8):7320–7328. doi:10.1007/s12274-022-4359-6
   Web of Science ®Google Scholar
• Tang G, He J, Liu J, Yan X, Fan K. Nanozyme for tumor therapy: surface modification matters. Exploration. 2021;1(1):75–89. doi:10.1002/EXP.20210005
   Google Scholar
• Phan NM, Nguyen TL, Kim J. Nanozyme-based enhanced cancer immunotherapy. Tissue Eng Regen Med. 2022;19(2):237–252. doi:10.1007/s13770-022-00430-y
   PubMed Web of Science ®Google Scholar
• Dong C, Dai X, Wang X, et al. A calcium fluoride nanozyme for ultrasound-amplified and Ca2+-overload-enhanced catalytic tumor nanotherapy. Adv Mater. 2022;34(43):2205680. doi:10.1002/adma.202205680
   Web of Science ®Google Scholar
• Liu J, Wang A, Liu S, et al. A titanium nitride nanozyme for pH-responsive and irradiation-enhanced cascade-catalytic tumor therapy. Angew Chem Int Ed Engl. 2021;60(48):25328–25338. doi:10.1002/anie.202106750
   PubMed Web of Science ®Google Scholar
• Nan F, Jia Q, Xue X, et al. Iron phthalocyanine-derived nanozyme as dual reactive oxygen species generation accelerator for photothermally enhanced tumor catalytic therapy. Biomaterials. 2022;284:121495. doi:10.1016/j.biomaterials.2022.121495
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhao J, Chen Y, et al. MoS2-ALG-Fe/GOx hydrogel with Fenton catalytic activity for combined cancer photothermal, starvation, and chemodynamic therapy. Colloids Surf B Biointerfaces. 2020;195:111243. doi:10.1016/j.colsurfb.2020.111243
   PubMed Web of Science ®Google Scholar
• Cheng X, Yong Y, Dai Y, et al. Enhanced radiotherapy using bismuth sulfide nanoagents combined with photo-thermal treatment. Theranostics. 2017;7(17):4087–4098. doi:10.7150/thno.20548
   PubMed Web of Science ®Google Scholar